Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL5062989

C=CC(C)(C)OP(=O)(OC(C)(C)C=C)OP(=O)(OC(C)(C)C=C)OC(C)(C)C=C.O=P(O)(O)OP(=O)(O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.42
BLM P54132 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL156445 0.89
Pyrophosphoric Acid SCHEMBL3890468 0.83 FDPS (0.42) FDPSBLMTDP1
SCHEMBL156446 0.81 BTN3A1 (0.38) FDPSBLMTDP1
SCHEMBL1004249 0.80 SMPD1 (0.33) FDPSBLMTDP1
SCHEMBL1086087 0.79
Ammonia Solution, Strong SCHEMBL3690678 0.79 BTN3A1 (0.37) FDPSBLMTDP1
Ammonia Solution, Strong SCHEMBL3690680 0.79 BTN3A1 (0.37) FDPSBLMTDP1
SCHEMBL18486678 0.78 BTN3A1 (0.36) FDPSBLMTDP1
Pyrophosphoric Acid SCHEMBL16011213 0.76 BTN3A1 (0.39) FDPSBLMTDP1
SCHEMBL9901912 0.76 LMNA (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070268-A1 Differential expression profiling analysis of cell culture phenotypes and the uses thereof WYETH (US) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070268-A1 Differential expression profiling analysis of cell culture phenotypes and the uses thereof ANKRD52, PPP4R3A, PPP6R3 FDPS 3539/4885BLM 4653/4885TDP1 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.